• Featured Product
  • KD/KO Validated

WWTR1 Polyclonal antibody

WWTR1 Polyclonal Antibody for IF, IP, WB, ELISA

Host / Isotype

Rabbit / IgG

Reactivity

human, rat and More (1)

Applications

WB,IP,IF,ELISA

Conjugate

Unconjugated

Cat no : 23306-1-AP

Synonyms

TAZ, WWTR1



Tested Applications

Positive WB detected inHeLa cells, LN229 cells, MDA-MB-453s cells
Positive IP detected inMDA-MB-453s cells
Positive IF detected inrat kidney tissue

Recommended dilution

ApplicationDilution
Western Blot (WB)WB : 1:1000-1:8000
Immunoprecipitation (IP)IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate
Immunofluorescence (IF)IF : 1:50-1:500
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Product Information

23306-1-AP targets WWTR1 in WB,IP,IF,ELISA applications and shows reactivity with human, rat samples.

Tested Reactivity human, rat
Cited Reactivityhuman, mouse, rat
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen WWTR1 fusion protein Ag19659
Full Name WW domain containing transcription regulator 1
Calculated Molecular Weight 44 kDa
Observed Molecular Weight 50 kDa
GenBank Accession NumberBC014052
Gene Symbol WWTR1
Gene ID (NCBI) 25937
RRIDAB_2721185
Conjugate Unconjugated
Form Liquid
Purification MethodAntigen affinity purification
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.

Background Information

TAZ, also referred as WWTR1, is a transcriptional co-activator with a PDZ-binding motif that is regulated by its interaction with 14-3-3 protein. TAZ is expressed in many primary tumors, such as breast cancer, thyroid carcinoma, colorectal cancer, and glioma. TAZ has been reported to be one of the nuclear effectors of Hippo-related pathways that regulate organ size control, cancer stem cell (CSC) properties, and epithelial-mesenchymal transition (EMT). TAZ has been defined for its role in the nucleus, where it functions directly as a transcriptional regulator by interacting with several nuclear factors as Runx2/Cbfa1, NHERF-2, TEF-1, TBX5, PAX3, PAX8 and TTF-1.

Protocols

Product Specific Protocols
WB protocol for WWTR1 antibody 23306-1-APDownload protocol
IF protocol for WWTR1 antibody 23306-1-APDownload protocol
IP protocol for WWTR1 antibody 23306-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

SpeciesApplicationTitle
human,mouseIF,IP

Cancer Cell

Programming of Schwann Cells by Lats1/2-TAZ/YAP Signaling Drives Malignant Peripheral Nerve Sheath Tumorigenesis.

Authors - Lai Man Natalie Wu
humanWB,IHC

Nat Neurosci

YAP and TAZ control peripheral myelination and the expression of laminin receptors in Schwann cells.

Authors - Yannick Poitelon
  • KO Validated
mouse,humanWB

Sci Adv

YAP drives fate conversion and chemoresistance of small cell lung cancer.

Authors - Qingzhe Wu
  • KD Validated
mouseWB,IF

Bone Res

TAZ inhibits osteoclastogenesis by attenuating TAK1/NF-κB signaling.

Authors - Wanlei Yang
  • KO Validated
humanWB

Clin Transl Med

NSUN2 promotes colorectal cancer progression by enhancing SKIL mRNA stabilization

Authors - Shaomin Zou
humanChIP

Cancer Res

A Division of Labor between YAP and TAZ in Non-Small Cell Lung Cancer.

Authors - Michal Shreberk-Shaked

Reviews

The reviews below have been submitted by verified Proteintech customers who received an incentive forproviding their feedback.


FH

Yohanes (Verified Customer) (04-24-2023)

  • Applications: Western Blot, Immunofluorescence, Other
  • Primary Antibody Dilution: 1:1000 for WB, 1:200 for IF, 1:100 for PLA
  • Cell Tissue Type: bEnd.3 mouse Endothelial cell
FH

Joshua (Verified Customer) (02-28-2020)

MDCKs fixed in 4% paraformaldehyde. Bright Mix of nuclear and cytosolic staining

  • Applications: Immunofluorescence,
  • Primary Antibody Dilution: 1:500
  • Cell Tissue Type: MDCK
WWTR1 Antibody Immunofluorescence, validation (1:500 dilution) in MDCK (Cat no:23306-1-AP)